亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

ELN Genetic Risk Stratification Not Affect the Mid-Term Survival in Childhood AML: Report from Southern China Childhood AML Group

医学 CEBPA公司 内科学 肿瘤科 净现值1 儿科 髓系白血病 阿糖胞苷 移植 突变 生物 遗传学 基因 染色体 核型
作者
Xiaoqin Feng,Li J,Xiangling He,Hong‐Gui Xu,Mincui Zheng,Hong Wen,Yingyi He,Sixi Liu,Yongsheng Ruan,Chunfu Li
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 5183-5183
标识
DOI:10.1182/blood-2018-99-118332
摘要

Abstract OBJECTIVE: To evaluate the survival of children with acute myeloid leukemia (AML) in the ELN genetic risk stratification. To explore the precise treatment and efficacy in childhood AML. Methods: The information of genetics of 151 newly diagnosed AML children enrolled in the Southern China Childhood AML Collaboration Group from December 2014 to June 2017 were retrospectively analyzed. These patients was divided into low-risk, intermediate-risk and high-risk groups according to the ELN genetic risk stratification. All cases were treated with the Southern China Childhood AML Collaborative Group protocol. The induction of remission was not randomized using FLAG-IDA and DAE regimens for 2 courses of treatment. The consolidation therapy was performed using HAE and MidAC regimens. 20 cases underwent hematopoietic stem cell transplantation. The mediate follow-up time was 18 months. Survival analysis and Log-Rank test were investigated by Graphpad Prism software. RESULTS: Of 151 children with AML, AML1/ETO positive in 46(30.5%) cases, CBFβ/MYH11 positive in 12(7.9%) cases, MLL gene in 18(11.9%) cases (including MLLT3-KMT2A in 7 cases). There were mutation gene FTL3/ITD in 24(15.9%) cases, ASXL1 mutation In 10(6.6%) cases, NPM1 mutation in 3(2.0%) cases and CEBPA double mutation in 4(2.6%) cases. Chromosome -7 or 7q- was found in 5(3.3%) cases. According to the ELN genetic risk stratification, 60/151(39.7%), 52/151(34.4%) and 39/151(25.8%) of patients were classified as low-risk, intermediate-risk and high-risk respectively. In the cohort of DAE induction, the CR+CRi rate was 95%, 69% and 80% in the low-risk, intermediate-risk and high-risk group. In the cohort of FLAG-IDA induction, the CR+CRi rate was 100%, 95% and 100% in the low-risk, intermediate-risk and high-risk group. The significance of CR+CRi rate only were be seen in the intermediate-risk group( P=0.02). The 2 year overall OS and DFS were 82.56% and 75.74% respectively. The 2-year DFS of the FLAG-IDA and DAE groups were 85.38% and 53.72% respectively (P=0.0004). The 2-year DFS of the LR, IR, and HR groups in the FLAG-IDA group were 89.23%, 92.29%, and 91.67% respectively, and no statistical difference was found among the groups (P=0.909). The 2-year DFS of the chemotherapy group and the hematopoietic stem cell transplantation group were 82.24% and 63.38%. There were no statistical differences between the groups. Discussion: The FLAG-IDA induction group significantly improved DFS compared with the DAE group. Hematopoietic stem cell transplantation failed to improve the survival of children with AML in the short period in our multicentre study. Our mid-term results show that the ELN genetic risk stratification had not a significant impact on the prognosis of newly diagnosed childhood AML with high-intensity therapy. Disclosures No relevant conflicts of interest to declare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爱笑的鹿完成签到,获得积分10
2秒前
顺心安雁完成签到,获得积分10
4秒前
2589发布了新的文献求助10
4秒前
xccccccc发布了新的文献求助10
6秒前
科研通AI6.2的应助被露稚采纳,获得10
9秒前
wanci的应助被啊唔采纳,获得10
19秒前
25秒前
25秒前
学不完了完成签到 ,获得积分10
28秒前
无私的迎蓉完成签到,获得积分10
29秒前
啊唔发布了新的文献求助10
29秒前
平淡的白翠完成签到,获得积分10
29秒前
2589发布了新的文献求助10
29秒前
云墨琉年完成签到 ,获得积分10
36秒前
万能图书馆的应助被2589采纳,获得10
37秒前
啊唔完成签到 ,获得积分10
39秒前
linghanlan完成签到,获得积分10
55秒前
深情安青的应助被专注凌柏采纳,获得10
55秒前
诚心铅笔完成签到,获得积分10
1分钟前
obedVL完成签到,获得积分10
1分钟前
1分钟前
1分钟前
慈蔼的人完成签到 ,获得积分10
1分钟前
Onebyby发布了新的文献求助10
1分钟前
上官若男的应助被一颗柿子树采纳,获得10
1分钟前
小绵羊完成签到,获得积分10
1分钟前
1分钟前
梦的光点发布了新的文献求助10
1分钟前
乐观凝云完成签到,获得积分10
1分钟前
lihaoran完成签到,获得积分10
1分钟前
王哪跑12发布了新的文献求助10
1分钟前
酷波er的应助被Wd采纳,获得30
1分钟前
1分钟前
1分钟前
1分钟前
Wd完成签到,获得积分10
1分钟前
专注凌柏发布了新的文献求助10
1分钟前
Wd发布了新的文献求助30
1分钟前
molihuakai的应助被王哪跑12采纳,获得10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185124
求助须知:如何正确求助?哪些是违规求助? 9574047
关于积分的说明 21834014
捐赠科研通 7782575
什么是DOI,文献DOI怎么找? 3434500
关于科研通互助平台的介绍 2558743
邀请新用户注册赠送积分活动 2481201